The laboratory information system market is on a strong upward trajectory, with an expected year-over-year growth of 6.0%, reaching a valuation of USD 2,166.3 million in 2024. The market is projected to continue its robust expansion, achieving a value of approximately USD 3,620.3 million by 2034, supported by a Compound Annual Growth Rate (CAGR) of 5.3% over the next decade.
The growth of the LIS market is largely driven by the increasing adoption of cloud-based laboratory information systems. These solutions offer numerous advantages, including enhanced accessibility, scalability, and cost-effectiveness, which are contributing to their rising popularity among laboratories worldwide.
Examine an Enlightening – Report
Germany dominates the European market for laboratory information systems, having accounted for a 28.2% market share in 2014, followed by France. The U.K is expected to become a major market for laboratory information systems (LIS) in the coming years.
The European laboratory information systems market is segmented on the basis of products, types, components, delivery mode, end users, and countries. The product segment is divided into standalone LIS and integrated LIS. The types included in the report are clinical LIS and anatomical LIS. The components covered in the report are services and software. On-premise, remotely-hosted, and cloud-based are delivery modes discussed in the report. The end users’ segment is further classified into clinical diagnostic laboratories, hospitals, anatomical pathology laboratories, blood banks, and molecular diagnostic laboratories. The countries such as Germany, Italy, Spain, U.K., and France would experience tremendous growth.
The European Commission’s new framework, Horizon 2020 has been the largest ever research and innovation programme in Europe for various fields including life sciences with a budget of $95 billion (€77 billion) from 2014-2020. In October 2017, The European Commission announced its plans to invest $37 billion (€30 billion) of this fund during 2018-2020 including $2.5 billion (€2 billion) to support Open Science, and $740 million (€600 million) for the European Open Science Cloud, European data infrastructure and high-performance computing. Horizon 2020 opened funding opportunities for future and emerging technologies and ICT Work Programme for life science researchers. Thus, increasing R&D activities and government funding will ultimately boost the demand for effective data management and hence drive the laboratory informatics market in Europe.
Key Takeaways
- R&D is crucial for drug discovery and development. This in turn, boosts the demand for efficient lab and data management.
- Growing number of organizations involved in R&D are shifting from traditional old systems to digital laboratory solutions.
- In European region, Germany accounted for the largest share of 26.0% of the total R&D spending in 2016 in Europe as stated by R&D Magazine, 2017.
- According to UNESCO Institute for Statistics, Germany is among the top 10 countries, accounting for 80% of global spending on R&D.
- Germany spends 2.9% of GDP on R&D and have pledged to substantially increase public & private R&D spending as well as number of researchers by 2030, as part of the Sustainable Development Goals (SDGs).
Competitive Landscape
Top companies in the laboratory information systems market are constantly releasing new products to increase their market share. They are bolstering their global reach through mergers, partnerships, and acquisitions.
Recent Developments
In September 2022, McKesson Corporation signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies and distribution centers through June 2027.
Key Companies Profiled:
ECerner Corp, Evident, McKesson, Medical Information Technology, Epic Systems Corporation, SCC Soft Computer, Roper Technologies Inc., CompuGroup Medical, and LabWare
Key Segments Covered in the Laboratory Information Systems Industry Analysis
By Components:
- Software
- Hardware
- Services
By Delivery Mode:
- On-Premise
- Cloud-Based
By End User:
- Hospitals
- Clinics
- Independent Laboratories
- Others
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
